The ADTC Collaborative works with pharmaceutical companies to develop operational guidance for medicines granted EAMS status. The guidance outlines operational issues for the EAMS medicine for health boards including:
- supply arrangements
- patient information
- pharmacovigilance requirements
- EAMS termination arrangements
| Publication date | Medicine | Guidance document |
|---|---|---|
| Publication date 12 May 2025 | Medicine Triheptanoin | Guidance document |
| Publication date | Medicine | Guidance document |
| Publication date | Medicine | Guidance document |
| Publication date | Medicine | Guidance document |
| Publication date | Medicine | Guidance document |
| Publication date | Medicine | Guidance document |